BlackRock, Inc. 13D and 13G filings for Prometheus Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-03 12:09 pm Purchase |
2022-12-31 | 13G | Prometheus Biosciences, Inc. RXDX |
BlackRock Inc. BLK |
2,807,704 6.100% |
918,944 (+48.65%) |
Filing |
| 2022-05-09 3:23 pm Sale |
2022-04-30 | 13G | Prometheus Biosciences, Inc. RXDX |
BlackRock Inc. BLK |
1,888,760 4.800% |
-272,009 (-12.59%) |
Filing |
| 2022-02-04 4:12 pm Purchase |
2021-12-31 | 13G | Prometheus Biosciences, Inc. RXDX |
BlackRock Inc. BLK |
2,160,769 5.500% |
2,160,769 (New Position) |
Filing |